Camurati-Engelmann Disease - 25 Studies Found
Recruiting |
: Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer : Prostate Cancer : 2015-05-20 :
|
Completed |
: Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma : Asthma : 2007-09-27 : Drug: montelukast montelukast 5-mg chewable tablet with matching placebo once daily in the evening at be |
Active, not recruiting |
: Autologous/Allogeneic TGFbeta-resistant LMP2A-specific CTL, Lymphoma (TGF-beta) :
: 2010-10-19 |
Completed |
: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma :
: 2007-02-05 :
|
Terminated |
: Anti-TGF-beta Therapy in Patients With Myelofibrosis :
|
Recruiting |
: SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer :
: 2015-10-16 :
|
Completed |
: Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer :
: 2009-05-09 : |
Completed |
: Fresolimumab In Systemic Sclerosis : Diffuse Systemic Sclerosis : 2011-01-25 : Drug: Fresolimumab intravenous fresolimumab 1mg/kg, first 8 patients; 5 mg/kg following 8 patients |
Not yet recruiting |
: ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer : Rectal Adenocarcinoma : 2016-01-25 :
|